×
Login Home News & Events Donate Shop Research The Foundation Michael Sponsors Contact

Our Community


Cancer is a disease that knows no bounds or borders. The fight against childhood cancer is a battle that we share with everyone who is striving to improve the quality of life for sick children everywhere. The Michael Cuccione Foundation is honoured to provide funds to community groups, hospitals, and non-profit organizations across North America who share our dream in creating a world where all children are allowed to be children.

Vancouver


B.C. Children's Hospital
4480 Oak Street, Vancouver, British Columbia, Canada, V6H 3V4
B.C. Children's Hospital
112 2025 W. Broadway, Vancouver, British Columbia, V6J 1Z6

Edmonton


Stollery Children's Hospital
8440 112 Street NW, Edmonton, Alberta, Canada, T6G 2B7

Toronto


The Hospital for Sick Children
1275 York Avenue, New York, NY, USA 10021

Bursaries

Despite being only a young child himself, Michael realized that it was children who harboured the hope and potential for a brighter tomorrow, both on medical and societal frontiers. The Foundation is proud to give back to local communities by providing financial support to students who exemplify Michael's positive outlook and unyielding drive to succeed in the face of adversity. Currently funding several annual scholarships to exceptional youth, the Michael Cuccione Foundation encourages the children of today to be the leaders of tomorrow.

All bursaries require that candidates are in high academic standing, are athletically involved, contribute to their communities, and will be furthering their education at a post-secondary institution upon graduation. The staff at each school selects the successful recipient.

$1000.00 Bursary


Notre Dame Regional Secondary School
2855 Parker Street, Vancouver, British Columbia, Canada V5K 2T8

$1000.00 Bursary


Archbishop Carney Regional Secondary School
1335 Dominion Avenue, Port Coquitlam, British Columbia, Canada V3B 7M6

Latest in Childhood Cancer Research

Our scientists lead teams that, together, are making significant inroads into our understanding of cancer.